Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer

World Journal of Surgery

Volumn 34, Issue 12, 2010, Pages 2853-2859

  Alakus, Hakan ^a   Afriani, Noor ^a   Warnecke Eberz, Ute ^a   Bollschweiler, Elfriede ^a   Fetzner, Ulrich ^a   Drebber, Uta ^a   Metzger, Ralf ^a   Hölscher, Arnulf H ^a   Mönig, Stefan P ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH TUMOR; SURVIVAL;

FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 78651292655     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0761-4     Document Type: Article

References (17)

1. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174
2. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327-336
3. Curran S, Dundas SR, Buxton J et al (2004) Matrix metalloproteinase/ tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res 10:8229-8234
4. Murray GI, Duncan ME, O'Neil P et al (1998) Matrix metalloproteinase- 1 is associated with poor prognosis in oesophageal cancer. J Pathol 185:256-261
5. Sier CF, Kubben FJ, Ganesh S et al (1996) Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 74: 413-417
6. Mrena J, Wiksten JP, Nordling S et al (2006) MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer. J Clin Pathol 59:618-623
7. Mönig SP, Baldus SE, Hennecken JK et al (2001) Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma. Histopathology 39:597-602
8. Nomura H, Sato H, Seiki M et al (1995) Expression of membrane- type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55:3263-3266
9. Alakus H, Grass G, Hennecken JK et al (2008) Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer. Histol Histopathol 23:917-923
10. Kubben FJ, Sier CF, Meijer MJ et al (2006) Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer 95:744-751
11. Jormsjö S, Whatling C, Dirk H et al (2001) Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 21:1834-1839
12. Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma, 2nd English edition. Gastric Cancer 1:10-24
13. Wittekind C, Compton CC, Greene FL et al (2002) TNM residual tumor classification revisited. Cancer 94:2511-2516
14. Leone A, Flatow U, King CR et al (1991) Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 65:25-35
15. Price SJ, Greaves DR, Watkins H (2001) Identification of novel, functional genetic variants in the human matrix metalloproteinase- 2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 276:7549-7558
16. Miao X, Yu C, Tan W et al (2003) A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res 63:3987-3990
17. Zhang J, Jin X, Fang S et al (2005) The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 26:1748-1753 (Pubitemid 41487990)